Frozen Section Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans—A Case Series of 38 Patients in NSW , Australia
Australasian Journal of Dermatology · 2026
DOI: 10.1111/ajd.70010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australasian Journal of Dermatology, 2026. Verfasst von Marjia Johns und 5 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Specialist Healthcare Miranda, Australia. Hauptthemen laut MEDLINE: Mohs Surgery, Dermatofibrosarcoma, Skin Neoplasms. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous tumour with a locally infiltrative growth pattern that has high rates of recurrence. Mohs micrographic surgery is recommended as the gold‐standard treatment over wide local excision (WLE) due to tissue‐sparing and reduced recurrence rates. No previous data on surgical outcomes following Mohs Micrographic Surgery (MMS) for DFSP have been reported in Australia to date. This study aims to review the outcomes of DFSP treated with frozen‐section MMS across three centres in New South Wales (NSW), Australia, and compare these outcomes with those in the current literature.
Methods
A retrospective review of patients who underwent MMS for DFSP between 2010 and 2023 was performed. Patient demographics, histological findings, surgical treatment and follow‐up data were collected. Recurrence was assessed through electronic medical records, clinical assessments by a dermatologist or general practitioner, and patient self‐report.
Results
In all, 38 cases of DFSP were included (27 female, 11 male; median age 39 years, range 16–64). The trunk was the most common site. Clinical margins and Mohs stages were recorded in 37 of 38 cases, with 73% of cases cleared with clinical margins of ≤ 20 mm. Clinical or self‐reported follow‐up was available for 28 of 38 patients (73.6%) over a mean of 51 months (range, 5–132 months). No local recurrences were identified during this period.
Conclusion
This is the first Australian case series on MMS for DFSP. Our findings demonstrate no recurrences with follow‐up and demonstrate that MMS may achieve clearance with smaller clinical margins than WLE. These results support international guidelines recommending MMS as the gold‐standard treatment and highlight the need to improve access to MMS in Australia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Integrated Specialist Healthcare Miranda, Australia.
- Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
- The Skin Hospital, Westmead, New South Wales, Australia.
- Central Clinical School, Faculty of Medicine, University of Sydney, Camperdown, New South Wales, Australia.
- Department of Dermatology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
- University of Wollongong Graduate School of Medicine, Australia.
ORCID-Profile: Marjia Johns, Maya Deva, Gilberto Moreno Bonilla
Zitieren
APA
Johns, M., Deva, M., Bonilla, G. M., Lee, S., Stanford, D. G., & Loghdey, S. (2026). Frozen Section Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans—A Case Series of 38 Patients in NSW , Australia. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.70010
Vancouver
Johns M, Deva M, Bonilla GM, Lee S, Stanford DG, Loghdey S. Frozen Section Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans—A Case Series of 38 Patients in NSW , Australia. Australasian Journal of Dermatology. 2026. doi:10.1111/ajd.70010
BibTeX
@article{Johns2026,
author = {Johns, Marjia and Deva, Maya and Bonilla, Gilberto Moreno and Lee, Simon and Stanford, Duncan Graham and Loghdey, Saleem},
title = {Frozen Section Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans—A Case Series of 38 Patients in NSW , Australia},
journal = {Australasian Journal of Dermatology},
year = {2026},
doi = {10.1111/ajd.70010}
}
EUVIMED